MedTrace Logo

Methylation Status of CD44 Promoter Region in Primary Lung Cancer

NCT00173680 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2005-11-24

No results posted yet for this study

Summary

This project is to study the methylation status of the transcriptional regulatory region of CD44 gene in surgically resected NSCLC specimens and normal lung tissue, correlate the methylation status of promoter region with the expression of CD44 gene, and analyze if methylation is associated with survival.

Conditions

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • LINA LEE, MD,PhD · Department of Labrotoary Medicine, National Taiwan University Hospital Taipei

Eligibility

Min Age
0 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-08-31

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00173680 on ClinicalTrials.gov